Biolife Solutions (BLFS) Gross Margin (2010 - 2026)

Biolife Solutions (BLFS) has reported Gross Margin for 17 consecutive years, with 64.24% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Margin fell 76.0% year-over-year to 64.24% in Q2 2026; TTM through Jun 2026 was 61.94%, a 278.0% decrease from a year earlier, with the FY2025 full-year figure at 64.56%, down 255.0% from the prior year.
• Gross Margin was 64.24% for Q2 2026 at Biolife Solutions, up from 63.62% in the prior quarter.
• Over five years, Gross Margin peaked at 81.93% in Q4 2023 and troughed at 6.92% in Q4 2022.
• A 5-year average of 58.15% and a median of 63.93% in 2026 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin jumped 7502 bps in 2023 and tumbled 2996 bps in 2024, its largest moves.
• Over 5 years, Gross Margin stood at 6.92% in 2022, then surged by 1085 bps to 81.93% in 2023, then plunged by 37 bps to 51.97% in 2024, then decreased by 7 bps to 48.55% in 2025, then jumped by 32 bps to 64.24% in 2026.
• The last three Gross Margin figures came in at 64.24% (Q2 2026), 63.62% (Q1 2026), and 48.55% (Q4 2025), per Business Quant data.